Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
NCT: NCT07111390 · RECRUITING
Brief Summary
This pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham 60Hz intermittent light stimulation for 30 minutes daily (Monday through Friday) over three weeks. The light is delivered through a wearable headset. Clinical assessments will be conducted remotely at baseline, mid-point, post-treatment, and follow-up to measure changes in depressive symptoms.
Frequently Asked Questions
What is Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)?
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) is a clinical trial registered under NCT07111390. Current status: RECRUITING.
What is the status of NCT07111390?
The current status of NCT07111390 (Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)) is: RECRUITING.
When did Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) start?
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) started on 2025-08-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.